Peptide Nucleic Acid Clamping and Direct Sequencing in the Detection of Oncogenic Alterations in Lung Cancer: Systematic Review and Meta-Analysis

다국어 초록 (Multilingual Abstract)

Purpose: Molecular testing in non-small cell lung cancer (NSCLC) aids in identifying oncogenic alterations. The aim of this study was to compare the rates of detection of oncogenic alterations and responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) according to EGFR mutation status as determined by peptide nucleic acid (PNA) clamping or directsequencing (DS).
Materials and Methods: We performed a systematic literature search using MEDLINE, EMBASE, and the Cochrane Central Register.
Data from included studies were pooled to yield summary sensitivity, specificity, positive and negative likelihood ratios, diagnosticodds ratio, and receiver operating characteristic curves. A meta-regression analysis was conducted to identify potential sources of heterogeneity between selected studies.
Results: We identified 10 studies comprising 924 patients. Oncogenic alterations were detected in 340 of 924 cases (36.8%) with PNA clamping and in 250 of 924 (27.1%) with DS. The pooled sensitivities of PNA clamping and DS were 0.93 [95% confidence interval(CI): 0.90−0.95] and 0.69 (95% CI: 0.64−0.73), respectively. According to meta-regression analysis, none of the covariates were found to be significant sources of heterogeneity. With respect to treatment responses to EGFR-TKIs, there was no significant difference therein between EGFR mutations detected by PNA clamping and DS (53.4% vs. 50.8%; risk ratio, 0.99; 95% CI 0.83−1.19; p=0.874).
Conclusion: We demonstrated that PNA clamping has a higher sensitivity than DS for detecting oncogenic alterations in NSCLC. Our findings suggest that PNA clamping is a more useful method for clinical practice.

참고문헌 (Reference)

1 이계영, "비소세포폐암에서 PNA-Mediated PCR Clamping을 이용한 EGFR 돌연변이 분석법" 대한결핵및호흡기학회 69 (69): 271-278, 2010

2 Thompson SG, "Why sources of heterogeneity in meta-analysis should be investigated" 309 : 1351-1355, 1994

3 Sakurada A, "Tissue heterogeneity of EGFR mutation in lung adenocarcinoma" 3 : 527-529, 2008

4 Deeks JJ, "The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed" 58 : 882-893, 2005

5 Whiting P, "The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews" 3 : 25-, 2003

6 Yeh YC, "Pulmonary adenocarcinoma with microcystic histology and intratumoral heterogeneity of EGFR gene polymorphism" 57 : 112-120, 2010

7 Moher D, "Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement" 151 : 264-269, 2009

8 Kim HS, "Predictive efficacy of low burden EGFR mutation detected by next-generation sequencing on response to EGFR tyrosine kinase inhibitors in non-small-cell lung carcinoma" 8 : e81975-, 2013

9 Reck M, "Precision diagnosis and treatment for advanced non-small-cell lung cancer" 377 : 849-861, 2017

10 윤승훈, "Peptide Nucleic Acid Clamping Versus Direct Sequencing for the Detection of EGFR Gene Mutation in Patients with Non-small Cell Lung Cancer" 대한암학회 47 (47): 661-669, 2015

11 Lindeman NI, "Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology" 137 : 828-860, 2013

12 이보람, "KRAS Mutation Detection in Non-small Cell Lung Cancer Using a Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping Method and Comparative Validation with Next-Generation Sequencing" 대한병리학회 48 (48): 100-107, 2014

13 Taniguchi K, "Intratumor heterogeneity of epidermal growth factor receptor mutations in lung cancer and its correlation to the response to gefitinib" 99 : 929-935, 2008

14 Yatabe Y, "Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma" 29 : 2972-2977, 2011

15 Pao W, "Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method" 13 : 4954-4955, 2007

16 Endo K, "Epidermal growth factor receptor gene mutation in nonsmall cell lung cancer using highly sensitive and fast TaqMan PCR assay" 50 : 375-384, 2005

17 Lijmer JG, "Empirical evidence of design-related bias in studies of diagnostic tests" 282 : 1061-1066, 1999

18 김희정, "EGFR 돌연변이 검출에 있어 PNA-Mediated Real-Time PCR Clamping과 직접 염기서열 분석법의 비교 분석" 대한결핵및호흡기학회 70 (70): 21-27, 2011

19 Han HS, "Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differential sensitivity" 7 : 355-364, 2012

20 Kim HJ, "Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with nonsmall cell lung cancer" 75 : 321-325, 2012

21 Yeo CD, "Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencing" 81 : 207-212, 2013

22 Pirker R, "Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop" 5 : 1706-1713, 2010

23 Won JK, "Concomitant ALK translocation and EGFR mutation in lung cancer: a comparison of direct sequencing and sensitive assays and the impact on responsiveness to tyrosine kinase inhibitor" 26 : 348-354, 2015

24 Kang JY, "Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion" 20 : 138-146, 2015

25 Min KW, "Comparison of EGFR mutation detection between the tissue and cytology using direct sequencing, pyrosequencing and peptide nucleic acid clamping in lung adenocarcinoma: Korean multicentre study" 109 : 167-173, 2016

26 이현주, "Comparison of Direct Sequencing, PNA Clamping-Real Time Polymerase Chain Reaction, and Pyrosequencing Methods for the Detection of EGFR Mutations in Non-small Cell Lung Carcinoma and the Correlation with Clinical Responses to EGFR Tyrosine Kinase Inhibitor Treatment" 대한병리학회 47 (47): 52-60, 2013

27 Reitsma JB, "Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews" 58 : 982-990, 2005

28 Dinnes J, "A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy" 9 (9): 2005